Resistance to cisplatin in NSCLC, achieved through autophagy, is a hindrance and andrographolide is found capable of inhibiting autophagy in cisplatin-resistant NSCLC by activating the Akt/mTOR pathway, and re-sensitizes tumor cells towards cisplatin [126]. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.